SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Wahlund LO) srt2:(1995-1999)"

Search: WFRF:(Wahlund LO) > (1995-1999)

  • Result 1-10 of 38
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Bronge, L, et al. (author)
  • White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype
  • 1999
  • In: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 10:2, s. 89-96
  • Journal article (peer-reviewed)abstract
    • To analyse the influence of apolipoprotein E (APOE) genotype on the extent of white matter lesions (WMLs) in Alzheimer’s disease (AD), we examined 60 AD patients with magnetic resonance imaging. The WMLs were rated visually in different brain regions. The patients with the APOE genotype σ4/4 had more extensive WMLs in the deep white matter than patients with genotypes σ3/3 and σ3/4. There was a correlation with age for WMLs in the deep white matter in patients with the APOE σ3/3 genotype. In patients carrying at least one σ4 allele, the WMLs showed no age correlation. The results could imply that in APOE allele σ4 carriers, the WMLs represent a pathological process related to the aetiology of the disease.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Ingelson, M, et al. (author)
  • Tau immunoreactivity detected in human plasma, but no obvious increase in dementia
  • 1999
  • In: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 10:6, s. 442-445
  • Journal article (peer-reviewed)abstract
    • <i>Tau</i> proteins are central to the neuropathology of Alzheimer’s disease and <i>tau</i> levels in cerebrospinal fluid are elevated in affected individuals. In this study, we investigated the presence of <i>tau</i> in plasma from subjects with Alzheimer’s disease (n = 16), frontotemporal dementia (n = 10), vascular dementia (n = 16) and from healthy controls (n = 15). By using an ELISA with monoclonal <i>tau</i> antibodies, <i>tau</i> immunoreactivity was detected in approximately 20% of the subjects. However, no difference between the disease and control groups was seen. After gel filtration of <i>tau</i> immunopositive plasma, the peak reactivity was found in the 160-kD fraction, indicating the source to be <i>tau</i>-like molecules of high-molecular-weight or polymers of low-molecular-weight <i>tau</i> isoforms. We conclude that measurements of <i>tau</i> in plasma cannot be utilized diagnostically for Alzheimer’s disease or for the other dementias investigated.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 38

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view